Focused ultrasound‐mediated APOE4 knockdown in mouse brain
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70464 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Kaiyuan Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Columbia University, New York, New York, USA. Hauptthemen laut MEDLINE: Apolipoprotein E4, Gene Knockdown Techniques, Brain, Hippocampus. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Focused Ultrasound Foundation, NINDS NIH HHS, NIH SCGE Program.
Abstract (Originalsprache)
INTRODUCTION The apolipoprotein E ( APOE ) ε4 allele is widely recognized as the strongest genetic risk factor for late‐onset Alzheimer's disease. Therapeutic strategies to reduce apoE4 expression in APOE ε4 carriers hold promise to mitigate neuroinflammatory and neurodegenerative processes driving disease progression. METHODS Focused ultrasound (FUS) was employed to transiently open the blood–brain barrier (BBB) for efficient knockdown of humanized APOE ε4 in the mouse brain via gene editing. The all‐in‐one clustered regularly interspaced short palindromic repeats (CRISPR)–based adeno‐associated virus (AAV) vectors were administered intravenously at a dose of 1.5×10 12 vg per mouse to determine the gene‐editing efficacy within the hippocampus. RESULTS FUS‐enhanced delivery of AAV resulted in a 12.6% knockdown of APOE ε4 gene expression in the targeted hippocampus, accompanied by an over 20% decrease in apoE4 protein levels and significant reductions in astrocyte and microglia levels. DISCUSSION Our findings demonstrate a noninvasive, targeted approach for APOE ε4 knockdown, highlighting FUS‐mediated brain‐directed interventions as a promising therapeutic strategy for Alzheimer's disease. Highlights Focused ultrasound (FUS) enables noninvasive, transient blood–brain barrier (BBB) opening for enhanced adeno‐associated virus (AAV) delivery. FUS‐mediated gene editing achieves a 12.6% knockdown in APOE ε4 expression within the hippocampus of mouse brain. APOE ε4 knockdown significantly reduces apoE4 protein levels and astrocyte and microglia levels. No detectable gross toxicity was observed following the FUS‐mediated gene editing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Columbia University, New York, New York, USA.
- Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, New York, USA.
- Department of Radiology, Columbia University Medical Center, New York, New York, USA.
- Department of Systems Biology, Columbia University Medical Center, New York, New York, USA.
Förderung
- Focused Ultrasound Foundation
- NINDS NIH HHS
- NIH SCGE Program
- NCI NIH HHS
- NIA NIH HHS
- NIBIB NIH HHS
- Onassis Foundation
- Alexander S. Onassis Public Benefit Foundation
Zitieren
APA
Zheng, K., Tsitsos, F. N., Batts, A. J., Ji, R., Nuriel, T., Konofagou, E. E., & Leong, K. W. (2025). Focused ultrasound‐mediated APOE4 knockdown in mouse brain. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70464
Vancouver
Zheng K, Tsitsos FN, Batts AJ, Ji R, Nuriel T, Konofagou EE, et al. Focused ultrasound‐mediated APOE4 knockdown in mouse brain. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70464
BibTeX
@article{Zheng2025,
author = {Zheng, Kaiyuan and Tsitsos, Fotios N and Batts, Alec J and Ji, Robin and Nuriel, Tal and Konofagou, Elisa E and Leong, Kam W},
title = {Focused ultrasound‐mediated APOE4 knockdown in mouse brain},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70464}
}
EUVIMED